Both the American Academy of Ophthalmology (AAO) and the European Glaucoma Society (EGS) have updated their preferred practice regimens to recognize or recommend SLT as an initial intervention for glaucoma and the NICE UK are now guiding doctors to use SLT before drops.
Driven by the pivotal six-year results of the LiGHT study, the glaucoma treatment paradigm has shifted away from medication-first and toward initial laser treatment.
Watch the videos below to hear Dr Paul Singh and Prof Gus Gazzard share their thoughts on the importance of laser first.
Prof. Gus Gazzard discusses the importance of laser as a first-line therapy for glaucoma.
